Characterization of 'non-N-methyl-D-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures
- PMID: 11279275
- DOI: 10.1046/j.1471-4159.2001.t01-1-00250.x
Characterization of 'non-N-methyl-D-Aspartate' binding sites for gacyclidine enantiomers in the rat cerebellar and telencephalic structures
Abstract
Gacyclidine is a non-competitive NMDA receptor antagonist with potent neuroprotective properties. However, we have previously demonstrated that gacyclidine enantiomers [(-) and (+)GK11] interact with other ('non-NMDA') binding sites which may play a role in the lower self-neurotoxicity of this compound relative to the other NMDA receptor antagonists. Evidence for these binding sites has been obtained from autoradiographic and membrane binding experiments. They were found to be expressed at high levels in the molecular layer of the cerebellum, although they can also been seen in the granular layer and in telencephalic regions. The present study was designed to further characterize these gacyclidine 'non-NMDA' binding sites. The pharmacological profiles obtained on cerebellar and telencephalic membrane homogenates showed that they could not be linked directly to the main receptors or uptake complexes of the central nervous system (CNS). However, the comparison of (-) and (+)[(3)H]GK11 binding distribution in different mutant animals bearing specific cellular deficits in the cerebellum has demonstrated that the gacyclidine 'non-NMDA' binding sites are associated with the dendritic trees of Purkinje cells. Interestingly, our study also shows that the radioligand binding to both cerebellar and telencephalic structures could be modulated by endogenous factors which can be removed by a stringent prewashing procedure.
Similar articles
-
Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.CNS Drug Rev. 2001 Summer;7(2):172-98. doi: 10.1111/j.1527-3458.2001.tb00194.x. CNS Drug Rev. 2001. PMID: 11474423 Free PMC article. Review.
-
Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.J Neurosci Res. 2002 May 1;68(3):305-14. doi: 10.1002/jnr.10203. J Neurosci Res. 2002. PMID: 12111860
-
Interaction of gacyclidine enantiomers with 'non-NMDA' binding sites in the rat central nervous system.Brain Res. 2001 Mar 16;894(2):189-92. doi: 10.1016/s0006-8993(00)03091-2. Brain Res. 2001. PMID: 11251192
-
Binding properties of [3H]gacyclidine (cis(pip/me)-1-[1-(2-thienyl)-2-methylcyclohexyl]piperidine) enantiomers in the rat central nervous system.Brain Res. 2000 Mar 24;859(2):177-92. doi: 10.1016/s0006-8993(99)02420-8. Brain Res. 2000. PMID: 10719063
-
Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman.Neurotoxicology. 1999 Aug;20(4):675-84. Neurotoxicology. 1999. PMID: 10499365 Review.
Cited by
-
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.PLoS One. 2013 Nov 19;8(11):e81004. doi: 10.1371/journal.pone.0081004. eCollection 2013. PLoS One. 2013. PMID: 24260528 Free PMC article.
-
Effects of extracochlear gacyclidine perfusion on tinnitus in humans: a case series.Eur Arch Otorhinolaryngol. 2010 May;267(5):691-9. doi: 10.1007/s00405-009-1126-1. Epub 2009 Oct 22. Eur Arch Otorhinolaryngol. 2010. PMID: 19847455
-
Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.CNS Drug Rev. 2001 Summer;7(2):172-98. doi: 10.1111/j.1527-3458.2001.tb00194.x. CNS Drug Rev. 2001. PMID: 11474423 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases